(R)-Hexahydro-oxazolo[3,4-a]pyrazin-3-one hydrochloride is a chiral heterocyclic compound featuring a fused oxazolo-pyrazinone scaffold. This bicyclic structure incorporates both nitrogen and oxygen atoms, making it a valuable constrained scaffold in medicinal chemistry. It is typically supplied as a hydrochloride salt to enhance its stability and solubility. This compound is primarily utilized as a key intermediate or a privileged scaffold in the synthesis of complex bioactive molecules, particularly in the field of peptide and peptidomimetic drug discovery. Its rigid, three-dimensional structure is valuable for mimicking peptide secondary structures and for constructing macrocyclic compounds. It serves as a crucial building block for developing novel protease inhibitors and other therapeutic agents targeting protein-protein interactions. The (R)-enantiomer provides specific stereochemistry, which is often critical for achieving desired biological activity and selectivity. As a specialized intermediate, it is used in research and development for creating new chemical entities with potential pharmaceutical applications, rather than as a bulk commodity or a general-purpose reagent.